Endothelial cell application centre expands support for researchers
Posted: 15 August 2017 | Dr Zara Kassam (European Pharmaceutical Review) | No comments yet
Lonza has announced an endothelial cell application centre, which expands support for researchers…
Today Lonza announced an endothelial cell application centre, which expands support for researchers. This new online suite provides scientists with educational materials and product information to assist with vital endothelial cell research.
The easy-to-navigate endothelial cell application centre is categorised by research area and can be accessed online anytime and anywhere, making it a handy tool for scientists to use on-demand. The centre provides a comprehensive portal of support resources, including technical whitepapers, research publications and product information for applications ranging from inflammation and angiogenesis to cardiovascular disease.
As endothelial cells are particularly hard to co-culture, the support centre contains materials that provide direction and address questions on setting up more challenging in vitro cultures, such as for blood-brain barrier modelling and tissue engineering. In addition to the resources available in the application centre also provides custom one-to-one support to further assist scientists with their endothelial cell research.
Lubna Hussain, Senior Global Product Manager for Primary Cells, Lonza, said: “Lonza is committed to supporting the work of scientists and with endothelial cells playing a crucial role in the pathology and treatment of many diseases, we felt it was important to create a centralised portal of materials to assist this research. Resources in our new application centre can be viewed online from anywhere and are free to download.”
The centre offers an extensive range of authenticated, ready-to-use human primary endothelial cells. The portfolio contains more than 30 varieties of human primary endothelial cells from tissue sources ranging from heart, lung, and skin, to the reproductive organs, and includes cells from type I and type II diabetic donors.
As endothelial cells regulate many homeostatic processes within the body, their dysfunction has important implications for diseases, such as diabetes, cardiovascular disease and cancer. Increasing our understanding of endothelial cells could help researchers to develop more effective drugs to treat these diseases.